(Q46825326)

25 December 2017

title

Solid lipid nanoparticles as delivery systems for bromocriptine (English)

1 reference

25 December 2017

0 references

6

1 reference

25 December 2017

Matteo Marti

object named as

Matteo Marti

3

0 references

author name string

Elisabetta Esposito

1

1 reference

25 December 2017

Martina Fantin

2

1 reference

25 December 2017

Markus Drechsler

4

1 reference

25 December 2017

Lydia Paccamiccio

5

1 reference

25 December 2017

Elisa Sivieri

7

1 reference

25 December 2017

Francesco Lain

8

1 reference

25 December 2017

Enea Menegatti

9

1 reference

25 December 2017

Michele Morari

10

1 reference

25 December 2017

Rita Cortesi

11

1 reference

25 December 2017

publication date

3 January 2008

1 reference

25 December 2017

published in

Pharmaceutical Research

1 reference

25 December 2017

volume

25

1 reference

25 December 2017

issue

7

1 reference

25 December 2017

page(s)

1521-1530

1 reference

25 December 2017

A clinicopathologic study of 100 cases of Parkinson's disease

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-007-9514-Y

Optimization of the preparation of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine pharmacosomes using central composite design

21 January 2018

1 reference

12 December 2020

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

1 reference

12 December 2020

Cubic phases of lipid-containing systems. Structure analysis and biological implications

1 reference

12 December 2020

Solid lipid nanoparticles: production, characterization and applications

1 reference

12 December 2020

The blood-brain barrier efflux transporters as a detoxifying system for the brain

1 reference

12 December 2020

The role of pulsatile versus continuous dopamine receptor stimulation for functional recovery in Parkinson's disease

1 reference

12 December 2020

Drug delivery to damaged brain

1 reference

12 December 2020

Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles.

1 reference

12 December 2020

Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?

1 reference

12 December 2020

The catalepsy test: its ups and downs

1 reference

12 December 2020

The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway.

1 reference

12 December 2020

New technologies for drug delivery across the blood brain barrier.

1 reference

12 December 2020

Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease.

1 reference

12 December 2020

Treatment interventions for Parkinson's disease: an evidence based assessment

1 reference

12 December 2020

Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting

1 reference

12 December 2020

Levodopa motor complications in Parkinson's disease

1 reference

12 December 2020

Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.

1 reference

12 December 2020

Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

1 reference

12 December 2020

Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain

1 reference

12 December 2020

In situ blood-brain barrier transport of nanoparticles

1 reference

12 December 2020

Brain drug delivery technologies: novel approaches for transporting therapeutics

1 reference

12 December 2020

Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?

1 reference

12 December 2020

Lipid-based supramolecular systems for topical application: a preformulatory study

1 reference

12 December 2020

Incorporation of the model drug ubidecarenone into solid lipid nanoparticles

1 reference

12 December 2020

Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy

1 reference

12 December 2020

A review of nanocarrier-based CNS delivery systems

1 reference

12 December 2020

Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems

1 reference

12 December 2020

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

1 reference

12 December 2020

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity

1 reference

12 December 2020

Nanoparticulate systems for brain delivery of drugs

1 reference

12 December 2020

Brain uptake of thiamine-coated nanoparticles

1 reference

12 December 2020

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

1 reference

12 December 2020

A review of the receptor-binding and pharmacokinetic properties of dopamine agonists

1 reference

12 December 2020

Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization.

1 reference

12 December 2020

Nanoparticle technology for delivery of drugs across the blood-brain barrier

1 reference

12 December 2020

Production of solid lipid nanoparticles (SLN): scaling up feasibilities.

1 reference

12 December 2020

De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset

1 reference

12 December 2020

10.1007/S11095-007-9514-Y

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017